Faculty Advisor(s)
Elaine Halesey
Abstract
Mammography is a crucial imaging technique for the early detection of breast cancer, utilizing low-energy X-rays to identify changes in breast tissue that may indicate malignancy. The American College of Radiology and the Society of Breast Imaging suggest annual mammograms starting at age 40, significantly improving outcomes such as mortality reduction and earlier diagnosis. In the U.S., breast cancer remains the most common cancer among women, with approximately 310,720 new invasive cases projected in 2024 and an estimated 42,250 fatalities. Ductal carcinoma in situ (DCIS), a non-invasive type of breast cancer, is seen as a precursor to invasive cancer, detectable through mammography via calcifications, often without symptoms. Risk factors for DCIS include a family history of breast cancer, delayed menopause, and genetic mutations such as BReast CAncer gene 1 (BRCA1) and BReast CAncer gene 2 (BRCA2). Accurate diagnosis typically involves mammographic evaluations categorized using the Breast Imaging Reporting and Data System (BI-RADS) system, followed by biopsies when necessary. Treatment for DCIS often begins with surgical options such as lumpectomy, followed by radiation therapy to reduce recurrence risks. Radiation therapy plays an important role in the treatment of DCIS. Genetic testing and proper follow-up care further enhance management, emphasizing the need for personalized treatment strategies in addressing this prevalent disease.
Publication Date
2024
Document Type
Poster
Department
Medical Imaging
Keywords
mammography, breast cancer, Ductal Carcinoma in Situ (DCIS), treatment, radiation therapy
Disciplines
Medicine and Health Sciences
Recommended Citation
Misson, Brianna, "Detecting & Treating Ductal Carcinoma in Situ" (2024). Medical Imaging Senior Posters. 48.
https://digitalcommons.misericordia.edu/medimg_seniorposters/48